Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies

Non-alcoholic fatty liver disease (NAFLD), the most common cause of liver disease, affects approximately 75 to 100 million Americans. Patients with concurrent NAFLD and type 2 diabetes mellitus have a higher risk of progressing to advanced fibrosis and non-alcoholic steatohepatitis compared to non-d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Transl Hepatol
Main Authors: Snyder, Heather S., Sakaan, Sami A., March, Katherine L., Siddique, Osama, Cholankeril, Rosann, Cummings, Carolyn D., Gadiparthi, Chiran, Satapathy, Sanjaya K., Ahmed, Aijaz, Cholankeril, George
Formato: Artigo
Idioma:Inglês
Publicado em: XIA & HE Publishing Inc. 2018
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018310/
https://ncbi.nlm.nih.gov/pubmed/29951362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2017.00050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados